850 KRW
36.97 B KRW
1.51 T KRW
23.25 M
About KWANGDONG PHARMACEUTICAL
Sector
CEO
Sung-Won Choi
Headquarters
Seoul
Website
Founded
1969
ISIN
KR7009290008
FIGI
BBG000BGYBX3
Kwang Dong Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceutical products. It operates through the following divisions: Pharmacy Sales, Hospital Sales, Distribution Sales, and Water Sales. The Pharmacy Sales division provides medicines for cold, high blood pressure, and cerebral apoplexy. The Hospital Sales division offers inoculation, health supplements, and vitamins. The Distribution Sales division provides health drinks and other drinks. The Water Sales division offers drinking water. The company was founded on October 16, 1969 and is headquartered in Seoul, South Korea.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 009290 is 5,700 KRW — it has increased by 0.71% in the past 24 hours. Watch KWANGDONG PHARMACEUTICAL stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange KWANGDONG PHARMACEUTICAL stocks are traded under the ticker 009290.
009290 stock has risen by 1.79% compared to the previous week, the month change is a 4.40% rise, over the last year KWANGDONG PHARMACEUTICAL has showed a −25.00% decrease.
009290 reached its all-time high on Jun 2, 2015 with the price of 19,100 KRW, and its all-time low was 1,010 KRW and was reached on Mar 12, 2004. View more price dynamics on 009290 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
009290 stock is 2.15% volatile and has beta coefficient of 0.73. Track KWANGDONG PHARMACEUTICAL stock price on the chart and check out the list of the most volatile stocks — is KWANGDONG PHARMACEUTICAL there?
Today KWANGDONG PHARMACEUTICAL has the market capitalization of 228.46 B, it has increased by 1.97% over the last week.
Yes, you can track KWANGDONG PHARMACEUTICAL financials in yearly and quarterly reports right on TradingView.
009290 net income for the last quarter is 8.82 B KRW, while the quarter before that showed 1.32 B KRW of net income which accounts for 566.29% change. Track more KWANGDONG PHARMACEUTICAL financial stats to get the full picture.
Yes, 009290 dividends are paid annually. The last dividend per share was 100.00 KRW. As of today, Dividend Yield (TTM)% is 1.75%. Tracking KWANGDONG PHARMACEUTICAL dividends might help you take more informed decisions.
KWANGDONG PHARMACEUTICAL dividend yield was 1.35% in 2023, and payout ratio reached 10.95%. The year before the numbers were 1.68% and 16.99% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 22, 2024, the company has 1.07 K employees. See our rating of the largest employees — is KWANGDONG PHARMACEUTICAL on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. KWANGDONG PHARMACEUTICAL EBITDA is 40.21 B KRW, and current EBITDA margin is 3.57%. See more stats in KWANGDONG PHARMACEUTICAL financial statements.
Like other stocks, 009290 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade KWANGDONG PHARMACEUTICAL stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So KWANGDONG PHARMACEUTICAL technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating KWANGDONG PHARMACEUTICAL stock shows the sell signal. See more of KWANGDONG PHARMACEUTICAL technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.